1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
1/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
基本信息
- 批准号:9789210
- 负责人:
- 金额:$ 10.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvisory CommitteesAdvocateAntineoplastic AgentsApplications GrantsAreaCancer Center Planning GrantCommunity OutreachComprehensive Cancer CenterComputersCritiquesDevelopmentDrug Discovery GroupsEducationEducational ActivitiesEducational CurriculumEnsureEquipmentEthnic groupEvaluationFeedbackFinancial ActivityFosteringFundingFutureGoalsGrantHuman ResourcesIncidenceIndividualInfrastructureInstitutionMalignant NeoplasmsMedicineMonitorOccupational activity of managing financesOffice of Administrative ManagementPharmaceutical PreparationsPharmacologic SubstancePhasePilot ProjectsPoliciesPrevalenceProgram DevelopmentQuestionnairesReportingResearchResearch ActivityResearch PersonnelResearch PriorityResearch Project GrantsResource AllocationResourcesRoleSelection CriteriaServicesTalentsUnderrepresented StudentsUniversitiesUpdateanticancer researchbasecancer health disparitycareercollegecostdrug candidatedrug discoveryeducation researchinterestmeetingsmembermultidisciplinaryoperationoutcome forecastprogramssatisfactionsocial mediastudent trainingsuccessundergraduate student
项目摘要
PROJECT SUMMARY (ADMINISTRATIVE CORE)
The overall objective of the Administrative Core is to provide centralized scientific, administrative, and financial
management and oversight of our P20 grant entitled “UHCOP–DLDCCC alliance: Cancer drug discovery/
development and education.” The Administrative Core will 1) foster scientific interactions within the P20 grant
project teams and between the P20 teams and other investigators associated with the pilot projects, 2) ensure
the P20 investigators maintain high-quality, successful research and activities to fulfill their Specific Aims and
objectives, and 3) oversee the development of education-based curricula [the Cancer Research Education
Program (CREP)] that educate underrepresented (UR) trainees in the area of cancer research and ethnic
group–based disparities in cancer incidence/prevalence/prognosis. The Administrative Core will provide
support for tracking grant fund utilization and prepare all reports and future grant submissions associated with
the P20. Drs. Martin M. Matzuk and Diana S.-L. Chow will be the primary individuals responsible for the
Administrative Core, will provide administrative and scientific management of the P20 grant, and will be
responsible for decisions regarding policy matters relating to research priorities or issues within the Pilot
Projects or CREP as well as the overall operation of the P20 grant. The Internal Advisory Committee [(IAC;
three multidisciplinary internal scientific and administrative leaders from each institution: Dan L. Duncan
Comprehensive Cancer Center (DLDCCC)/Baylor College of Medicine (BCM) and the University of Houston
(UH)] will provide advice and direction to Drs. Matzuk and Chow, the Pilot Projects, and CREP. The
Administrative Core will coordinate the quarterly meeting of the IAC. The IAC will provide guidance for each
Project and the CREP. Administrative support will be furnished by four talented professionals, two from each
institution and including UR individuals, who will provide multiple administrative and financial management
services and be advocates for our UR community outreach activities. The Administrative Core will be
conveniently located in BCM and in UHCOP buildings close to the Project Investigators at both institutions. All
Project and CREP Leaders will have access to financial, personnel, networking, and computer services. The
Pilot Projects and the CREP will utilize the Administrative Core equally. The Administrative Core and IAC will
guide the P20 Project and CREP Leaders on critical decisions for advancing or halting each project and will
contribute significantly to the success of this P20 proposal.
项目概要(行政核心)
行政核心的总体目标是提供集中的科学、行政和财政服务,
管理和监督我们的P20赠款,题为“UHCOP-DLDCCC联盟:癌症药物发现/
发展与教育”。行政核心将1)促进P20赠款内的科学互动
项目团队之间以及P20团队和与试点项目相关的其他调查人员之间,2)确保
P20研究人员保持高质量、成功的研究和活动,以实现其特定目标,
3)监督以教育为本的课程的发展[癌症研究教育
项目(CREP)],在癌症研究和种族歧视领域教育代表性不足(UR)的学员。
基于群体的癌症发病率/患病率/预后差异。行政核心将提供
支持跟踪赠款资金的使用情况,并准备所有报告和未来提交的赠款,
P20。Martin M.博士Matzuk和Diana S.- L.周将是主要负责人,
行政核心,将提供P20赠款的行政和科学管理,并将
负责就与试验计划内的研究优先次序或问题有关的政策事宜作出决定
项目或CREP以及P20赠款的整体运作。内部咨询委员会(IAC)
三个多学科的内部科学和行政领导人从每个机构:丹L。邓肯
综合癌症中心(DLDCCC)/贝勒医学院(Baylor College of Medicine)和休斯顿大学
(UH)]将为Matzuk和Chow博士、试点项目和CREP提供建议和指导。的
行政核心将协调临时行政理事会的季度会议。每个人都将为自己的行为提供指导。
项目和CREP。行政支持将由四名才华横溢的专业人员提供,
机构,包括工发组织代表个人,他们将提供多种行政和财务管理
服务,并成为我们UR社区外展活动的倡导者。行政核心将是
交通便利,位于Upper和UHCOP大楼,靠近两个机构的项目调查人员。所有
项目和CREP领导人将获得财务、人事、网络和计算机服务。的
试点项目和CREP将平等利用行政核心。行政核心和临时行政理事会将
指导P20项目和CREP领导人做出推进或停止每个项目的关键决策,
为P20提案的成功做出重要贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diana S-L. Chow其他文献
Diana S-L. Chow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diana S-L. Chow', 18)}}的其他基金
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
用于 HCC 治疗的具有双药物有效负载的聚合物胶束的 IND 前开发
- 批准号:
10669704 - 财政年份:2022
- 资助金额:
$ 10.47万 - 项目类别:
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
用于 HCC 治疗的具有双药物有效负载的聚合物胶束的 IND 前开发
- 批准号:
10407228 - 财政年份:2022
- 资助金额:
$ 10.47万 - 项目类别:
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
2/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
- 批准号:
9789842 - 财政年份:2018
- 资助金额:
$ 10.47万 - 项目类别:
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
1/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
- 批准号:
9789209 - 财政年份:2018
- 资助金额:
$ 10.47万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 10.47万 - 项目类别:
Standard Grant














{{item.name}}会员




